AmnioGraft

About Bio-Tissue

BioTissue is a commercial-stage company focused on regenerative healing using processed human birth tissue allografts. It operates in two core segments: ocular (e.g., Prokera for corneal healing) and surgical (e.g., AmnioGraft for wound care), though it recently divested its non-ocular surgical business to sharpen its focus on ophthalmology. The company's competitive edge is rooted in its CryoTek cryopreservation and SteriTek shelf-stable processing technologies, which aim to preserve key biological components lost in conventional processing. With over 40 years of collective R&D, 1M+ clinical applications, and a strong publication record, BioTissue is an established player in the biologics and tissue engineering space.

Therapeutic Areas

Other Surgical Wound Healing Drugs